Articles tagged with Drug Relapse
Researchers suggest separate weight-driven tables for different types of defendants, eliminating disparities in crack and methamphetamine sentences. The study proposes alternative approaches to define relative sentences for psychostimulants and opioids based on harms associated with each type of drug.
A new study published in the Journal of the American Heart Association found that methamphetamine use accounted for nearly 15% of heart attacks in a northern California study. People who suffered meth-related heart attacks were often young- to middle-aged men without traditional heart disease risk factors, highlighting the need for spe...
Visitors to a California region with numerous substance use disorder treatment centers experience higher levels of overdose, particularly out-of-state individuals. The study suggests that the industry's lack of oversight and predatory practices contribute to this hotspot.
Researchers found that introducing new objects in a nonsocial environment reduced fentanyl intake over time and helped rats stop seeking the drug faster. Enriched environments also showed lower levels of stress hormones, linked to relapse in standard conditions.
A comprehensive review of 54 randomized controlled trials found no evidence that medicinal cannabis is effective in treating anxiety, depression, or PTSD. However, the study suggests that medicinal cannabis may be beneficial for certain conditions, such as reducing seizures associated with epilepsy and managing pain.
Researchers at the University of Iowa Health Care identified acetazolamide as a potential target for preventing opioid use disorder relapse. The study found that blocking the activity of brain enzyme carbonic anhydrase 4 boosted acid-sensing ion channels, reducing drug-seeking behavior and relapse in mice.
Smokers who successfully quit with e-cigarettes and continue vaping may be reducing their risk of relapse. The study found that abstainers in the e-cigarette arm were less likely to relapse than those in the nicotine replacement therapy (NRT) arm.
The University of Houston is part of a statewide effort to fight the opioid epidemic by investigating opioid use disorder among people living with HIV in Harris County. Researchers aim to integrate prevention methods, including Screening, Brief Intervention, and Referral to Treatment (SBIRT), into treatment for those affected.
A new study suggests that psychological cessation fatigue is a key factor in smoking relapse among ex-smokers. The study found that exhaustion from constantly trying to remain a non-smoker can overwhelm coping skills and motivation, leading to increased risk of relapse.
The analysis explores how reduced fentanyl production costs affect the structure and conduct of the illegal opioid supply industry. It also assesses potential consequences for drug law enforcement organizations, finding modest declines in expenditures and income-generating crime.
A new study from the University of Colorado Anschutz Medical Campus introduces a more individualized approach to restarting methadone treatment for people with opioid use disorder. The findings suggest that tailoring methadone doses to each patient's unique circumstances can improve care without compromising safety.
Dr. Harriet de Wit's groundbreaking research bridges animal and human drug studies, demonstrating that MDMA enhances feelings of social connectedness and challenging addiction treatment strategies. Her discoveries have profound implications for treating trauma-related disorders globally.
A study at the University of North Carolina Chapel Hill found that brain immune cells, called microglia, drive drug craving by stripping away support structures in astrocytes. Blocking this process reduces relapse behaviors and may help reduce risk of relapse in people recovering from addiction.
A recent study by Carnegie Mellon University found that illegally manufactured fentanyl primarily enters the US via counties along the Canadian border. The analysis revealed these counties accounted for over 40% of large fentanyl seizures in 2023-2024, despite comprising only 3.1% of the national population. This finding undermines eff...
A study published in Brain found that the orbitofrontal cortex responds more strongly to drug content than other stimuli, even after treatment and abstinence. The researchers used an Academy Award-nominated movie to assess brain responses in individuals with heroin use disorder and healthy controls.
A team of researchers used machine learning to analyze changes in astrocyte cells' structure, shedding light on heroin addiction and relapse. The study, published in Science Advances, found that specific subpopulations of astroglia exhibit more pronounced morphological changes during drug use.
A novel brain study uncovers the critical role of the HDAC5 enzyme in regulating gene expression and neuronal activity, which can trigger relapse in individuals with substance use disorders. The study highlights a new molecular target for developing novel treatments to reduce relapse risk.
A recent study found that people trying to quit opioids and pain medication experience more relapses compared to others. The research highlights the need for tailored treatment approaches, as some substances require more quit attempts than others.
A new UC San Francisco study found that most 11- and 12-year-olds use TikTok and other social media platforms against the rules, showing signs of addiction. The study also revealed a quarter of children reported elements of addiction while using social media, linked to depression, eating disorders, ADHD, and disruptive behaviors.
A new study published in the Cochrane Database of Systematic Reviews suggests that varenicline, a prescription medication, and text message-based interventions can help people quit vaping. The findings are particularly promising for young people aged 13 to 24, who showed significant success with text message-based programs.
A new study found that approximately 2.2 million people who have stopped smoking for more than a year in England currently vape, with the majority using e-cigarettes as a quit-smoking aid. The prevalence of vaping among ex-smokers has increased sharply since 2021, particularly among younger age groups and heavier drinkers.
A North Carolina State University study found that only 12% of organizations providing residential opioid substance use services are licensed by the state. Only a quarter allow patients to access proven opioid agonist treatment (OAT), which has better outcomes and cuts overdose deaths in half.
Brigham researchers created an implantable device that continuously monitors vital signs and delivers naloxone when detecting opioid overdose. The 'iSOS' device has shown effectiveness in preclinical models, offering a potential solution to the devastating effects of the opioid epidemic.
Researchers at Medical University of South Carolina found that cocaine triggers a specific protein, NPAS4, which hijacks brain circuitry and promotes further drug use. Inhibiting these cells eliminates drug-seeking behavior in mice.
Researchers study T cells and monocytes interaction in the meninges before they attack the brain and spinal cord, potentially leading to new disease progression targets. The findings could provide a pathway to treating other neurological diseases like Alzheimer's and Parkinson's.
A preclinical model has successfully restored an opioid-weakened brain pathway in mice, preventing relapse and improving ability to stop behaviors. This breakthrough could lead to the development of future treatments that rehabilitate brain functioning associated with drug use.
Researchers found that American visitors to Florida were 63% more likely to die from a drug overdose compared to visitors to all other states. The high proportion of overdose deaths among visitors to Florida may be attributed to the state's 'Florida Shuffle' treatment loop and lack of regulation in pain management clinics.
A Rutgers study found that mindfulness-Oriented Recovery Enhancement (MORE) can improve women's emotion regulation and impulse control, reducing opioid cravings. The program boosted communication between brain areas involved in controlling negative emotions and drug cravings.
A newly developed prediction model can estimate a patient's risk of returning to opioid use within the first three weeks of treatment. The model, which was tested on data from over 2,200 adults, suggests that patients who have not experienced any positive or missed drug tests in the first three weeks have a 13% risk of relapse.
A new study suggests that treating insomnia can prevent opioid relapse in rats, and potentially in humans. The experimental insomnia drug DORA-12 reduced withdrawal symptoms and prevented drug-seeking behavior in rats experiencing oxycodone withdrawal.
A neglected brain region has been identified as a key player in addiction recovery. The supplementary motor cortex was found to be hyperexcitable in individuals with cocaine use disorders, even after withdrawal periods of 45 days. This discovery may lead to new treatment approaches using transcranial magnetic stimulation.
A randomized trial will be conducted to test whether sticking with the initial medication or switching to a different one increases quitting success. The study aims to provide guidance for clinicians on handling relapses and may explore the effectiveness of e-cigarettes as an alternative to traditional cigarettes.
Researchers at MUSC identified changes in pyramidal neurons contributing to drug seeking. Inhibiting enzyme protein kinase A restored normal function and reduced opioid-seeking behavior.
Researchers found that peer support specialists with a shared life experience were most valued for providing emotional and housing/employment support, helping inmates recover from opioid use disorder. Participants appreciated the empathetic and trustworthy relationships established with their peer navigators.
A new study found that bupropion, an antidepressant medication, can help people stop using cocaine while receiving methadone for opioid use disorder. Participants who received monetary incentives to quit cocaine saw a higher success rate when taking bupropion compared to those with placebo.
A new study published in BMC Public Health suggests that problematic social media use in preteens is linked to both positive and negative alcohol beliefs. Researchers found that 97% of social media posts display alcohol in a positive context, contributing to positive perceptions among adolescents.
Researchers at Texas A&M University School of Medicine have identified a specific brain circuit that characterizes how fentanyl affects the brain. Suppressing negative emotional states may increase a person's chance of overcoming opioid use disorder.
A research team developed a vaccine targeting synthetic opioid fentanyl to block its entry into the brain, preventing fatal effects. The breakthrough could have major implications for treating Opioid Use Disorder, with potential relapse prevention capabilities.
A study found that nearly half of Medicaid beneficiaries who completed opioid rehab did not receive follow-up care or medication-assisted treatment within a month. Patients with prior prescriptions for opioid use disorder medications were 24% more likely to get follow-up care and medication.
Researchers at Rutgers University found that patients who participate in multiple outpatient visits early in treatment are more likely to continue care. Nearly half of these patients remained in treatment for six months or more, compared to just 2.9% of those with less frequent visits.
A new study suggests that phone calls and video chats can help patients access care, especially for those with barriers to traditional in-person visits. The study found that veterans who received virtual visits were more likely to stay on buprenorphine treatment, but there were disparities by race, housing status, and age.
Astrocytes play a crucial role in regulating the response to drug cues, acting as brakes on neuronal communication. By slowing down overactive communication, astrocytes can reduce the drive to seek drugs and prevent relapse.
Researchers discovered that REM sleep disturbances are linked to increased risk of drug relapse, and that targeting MCH neurons may be a promising therapeutic approach. The study found that improving REM sleep reduced cocaine-seeking behavior in rats.
A Rutgers University study found that expanding prison opioid treatment programs could reduce the risk of overdose and death among ex-inmates. The researchers suggest that further education on post-release opioid risks is necessary to increase participation in these programs.
A new UCI study identifies a single brain pathway centered around dopamine cells responsible for cocaine withdrawal-induced anxiety and relapse-related behavior. The findings offer a potential target for therapeutic interventions to prevent relapse among drug users.
A pair of studies published by Washington State University scientists found that hyperbaric oxygen therapy can help individuals with opioid addiction reduce their methadone dose and better manage pain and withdrawal symptoms. The treatment involves breathing pure oxygen in a pressurized environment, resulting in significant dose reduct...
A study on women-only Alcoholics Anonymous meetings in Brazil found that participants experienced rejection and loneliness due to social stigma. The women-only format provided a safe space for self-expression and reclaimed dignity, differing from mixed meetings where men-focused testimonials prevailed.
Researchers at Virginia Tech found that people with 'slow' life-history strategies, focusing on future rewards, exhibited positive behaviors and were more likely to be in remission. In contrast, those with 'fast' life-history strategies, prioritizing immediate rewards, faced greater challenges during recovery.
Research identifies maladaptive nature of drug-seeking habits as key factor in perpetuating addiction and relapse. Drug-paired cues can activate flexible goal-directed behaviors, driven by negative emotional urgency.
A University of Minnesota Medical School study found that nicotine withdrawal can lead to overeating high-calorie foods, possibly linked to the brain's opioid system. This connection may hinder smoking cessation and increase the risk of relapse, emphasizing the need for better understanding the factors driving cravings for unhealthy food.
A new study found that high-efficacy multiple sclerosis drugs are more effective in reducing flare-ups and modifying progression compared to low-efficacy drugs. Participants with active secondary progressive MS who received high-efficacy medications experienced 30% fewer relapses and an average of 0.17 relapses per year.
Recent research on epigenetic mechanisms reveals the impact of alcohol on gene expression and biochemical processes. Candidate drugs that counteract these effects are being developed to advance tailored pharmacological treatments.
Researchers discovered that angioimmunoblastic T-cell lymphoma (AITL) relies on T-cell receptor (TCR) signaling and dassatinib, a multi-kinase inhibitor, effectively treats this disease.
A US population-based study found that medication treatment for opioid use disorder significantly reduces fatal overdose risk. Patients receiving treatment with opioid agonists had an 80% lower risk of dying from an opioid overdose compared to those without medication.
A study published in Neuropsychopharmacology found that targeting cell populations in the nucleus accumbens can prevent addiction relapse. Researchers used chemogenetic receptors to control activity in this brain region, successfully reducing relapse behavior in high-risk rats.
The National Institute on Alcohol Abuse and Alcoholism has awarded $3.1 million to the Medical University of South Carolina to continue testing medications that could help individuals with alcohol use disorder. The goal is to reduce vulnerability to relapse and improve treatment options for those affected by alcohol misuse.
Scientists at Scripps Research Institute have identified brain cells that suppress drug cravings, which could lead to improved addiction treatments. The discovery sheds new light on how the brain responds to environmental cues that prevent relapse, providing hope for more effective medicines in the future.
A large-scale clinical trial has demonstrated that cannabis-based medication can effectively reduce the rate of relapse in individuals with cannabis dependency. Participants treated with nabiximols used significantly less illicit cannabis and showed improvements in physical and psychological well-being.
A randomized, double-blind, placebo-controlled study found that eculizumab significantly reduced the risk of relapse in patients with neuromyelitis optica spectrum disorder. Nearly 98% of patients treated with eculizumab had not relapsed after 48 weeks, compared to 63% for those on the placebo.
A randomized controlled trial found that texting patients with schizophrenia improved medication adherence by 27%, reducing relapses and re-hospitalizations. The LEAN program, which combines lay health supporters and mobile texting, was effective in resource-poor settings.